Loading market dashboard
Neurogene Inc.
NGNEHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Neurogene Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $406.30M | $406.30M - $406.30M | $243.78M | $6.12 | 2 |
| Dec 2029 | $137.95M | $137.95M - $137.95M | $82.77M | -$1.848 | 2 |
| Dec 2028 | $66.60M | $66.60M - $66.60M | $39.96M | -$4.792 | 5 |
| Dec 2027 | $0.00 | $0.00 - $0.00 | $0.00 | -$5.526 | 0 |
| Dec 2026 | $462.5K | $462.5K - $462.5K | $277.5K | -$5.574 | 7 |
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$4.32 | 0 |
| Dec 2024 | $905.0K | $895.1K - $924.9K | $543.0K | -$4.259 | 4 |
| Dec 2018 | $25.00M | $25.00M - $25.00M | $15.00M | -$26.80 | 3 |